Arpeggio Biosciences Competitors and Similar CompaniesClear all
Arpeggio Biosciences's competitors and similar companies include Argenx and Intabio.
 Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. |  Intabio Intabio is a technology company which provides an analytical platform to transform and accelerate the development of biotherapeutic drugs. | ||
Founding Date | Founding Date 2017 | Founding Date 2008 | Founding Date 2015 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Boulder, US HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US | Locations Newark, US HQ |
Employees | Employees 13 | Employees 1,599 | Employees 2111% increase |
Funding | |||
Latest funding round | Latest funding round $ 3.2m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 18m (over 6 years ago) |
Total funding raised | Total funding raised $ 3.4m | Total funding raised $ 396.8m | Total funding raised $ 30.7m |
For sources of this data, please see the company profile
View Company Profiles
Argenx
HQ
Gent, BE
Employees
1,599
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View companyIntabio
HQ
Newark, US
Employees
21↑ 11% increase
Intabio is a technology company which provides an analytical platform to transform and accelerate the development of biotherapeutic drugs.
View company